Ayurveda intervention in Allergic rhinitis

A randomised controlled parallel study to compare the efficacy of Haridrakhanda to combination of Haridrakhanda and Anutailanasya in allergic rhinitis - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072613

Enrollment

140

Registered

2024-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group of 18 to 60 years at the time of enrolment, irrespective of gender. Clinical symptoms for at least 1 month or more. Presence of two or more nasal symptoms: watery rhinorrhoea, nasal obstruction, sneezing, and nasal itching. Total Nasal Symptom Score (TNSS) of 6 or more (0 no symptoms, 1 mild symptoms, 2 moderate symptoms, 3 severe symptoms). Willing to give written, informed consent to participate in this study and come for follow-ups as advised.

Exclusion criteria

Exclusion criteria: Patients with deviated nasal septum/ nasal polyps/ nasal growth/ adenoids/ asthma. Patients with impaired liver and kidney functions, anaemia, and unstable cardiovascular conditions or cerebrovascular conditions. Currently or previously treated for any malignancy. Patients on steroid therapy. Pregnant or lactating mothers. . Those who have any history of drug allergy to any of the investigational products. Illiterate patients without a literate relative/guardian who can explain the procedures and maintain the patient diary, • Patients suffering from chronic debilitating diseases like Uncontrolled DM, JDM, HIV, HBsAg, Non-consenting individuals Any other patients who are considered unsuitable for recruitment by the investigator

Design outcomes

Primary

Measure	Time frame
Nasal symptoms (watery rhinorrhea, sneezing, nasal obstruction, nasal itching) measured using the Total Nasal Symptom Score (TNSS) of allergic rhinitis patients at baseline and the end of interventionTimepoint: Total Nasal Symptom at baseline,28th and 56th day. IgE and AEC at Baseline and 28th day.Score	—

Secondary

Measure	Time frame
1.Change in Serum Immunoglobulin E level 2.Change in Absolute Eosnophil Count (AEC) 3.Physico-chemical parameters,TLC and HpTLC of Anu tailaTimepoint: Baseline and 28th day	—

Countries

India

Contacts

Public ContactDR KRISHNA RAO S

Central Ayurveda Research Institute,Bhubaneswar

drbhuyangc@gmail.com9037690951

Outcome results